Roland Mory

1.0k total citations
6 papers, 659 citations indexed

About

Roland Mory is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Biochemistry. According to data from OpenAlex, Roland Mory has authored 6 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 3 papers in Biochemistry. Recurrent topics in Roland Mory's work include Neuroscience and Neuropharmacology Research (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Roland Mory is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Amino Acid Enzymes and Metabolism (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Roland Mory collaborates with scholars based in Switzerland, United States and Italy. Roland Mory's co-authors include Joseph G. Wettstein, Jean‐Luc Moreau, Amyaouch Bradaïa, Sylvie Chaboz, Marius C. Hoener, Roger D. Norcross, Katrin Groebke Zbinden, Bruno Pouzet, Sean Durkin and Laurence Ozmen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Psychiatry and Psychopharmacology.

In The Last Decade

Roland Mory

6 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Mory Switzerland 6 476 399 86 75 74 6 659
István Gacsályi Hungary 14 327 0.7× 235 0.6× 72 0.8× 68 0.9× 66 0.9× 27 630
Keiko Ikemoto Japan 18 504 1.1× 335 0.8× 62 0.7× 81 1.1× 39 0.5× 63 853
Kenneth M. Johnson United States 14 653 1.4× 414 1.0× 67 0.8× 122 1.6× 74 1.0× 16 931
Sylvie Chaboz Switzerland 9 1.1k 2.2× 692 1.7× 81 0.9× 104 1.4× 76 1.0× 9 1.5k
Clinton E. Canal United States 19 568 1.2× 292 0.7× 64 0.7× 236 3.1× 36 0.5× 41 935
Torsten M. Meyer Germany 4 671 1.4× 496 1.2× 68 0.8× 102 1.4× 70 0.9× 11 850
Mauro Federici Italy 19 575 1.2× 379 0.9× 91 1.1× 92 1.2× 51 0.7× 35 922
Audrey Hashim United States 21 695 1.5× 503 1.3× 34 0.4× 93 1.2× 82 1.1× 36 948
Jun’ichi Semba Japan 19 508 1.1× 376 0.9× 126 1.5× 101 1.3× 103 1.4× 42 897
B. D. Kretschmer Germany 17 633 1.3× 256 0.6× 56 0.7× 188 2.5× 35 0.5× 26 851

Countries citing papers authored by Roland Mory

Since Specialization
Citations

This map shows the geographic impact of Roland Mory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Mory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Mory more than expected).

Fields of papers citing papers by Roland Mory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Mory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Mory. The network helps show where Roland Mory may publish in the future.

Co-authorship network of co-authors of Roland Mory

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Mory. A scholar is included among the top collaborators of Roland Mory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Mory. Roland Mory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Pinard, Emmanuel, Daniela Alberati, Rubén Alvarez‐Sánchez, et al.. (2014). 3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors. ACS Medicinal Chemistry Letters. 5(4). 428–433. 5 indexed citations
2.
Moreau, J‐L, Bruno Pouzet, Roland Mory, et al.. (2012). A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Molecular Psychiatry. 18(5). 543–556. 211 indexed citations
3.
Alberati, Daniela, Jean‐Luc Moreau, Judith A. Lengyel, et al.. (2011). Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia. Neuropharmacology. 62(2). 1152–1161. 108 indexed citations
4.
Revel, Florent G., Jean‐Luc Moreau, Raul R. Gainetdinov, et al.. (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proceedings of the National Academy of Sciences. 108(20). 8485–8490. 274 indexed citations
5.
Alberati, Daniela, Jean‐Luc Moreau, Roland Mory, Emmanuel Pinard, & Joseph G. Wettstein. (2010). Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential. Pharmacology Biochemistry and Behavior. 97(2). 185–191. 15 indexed citations
6.
Pen, Gwenaëlle Le, et al.. (2002). Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology. 161(4). 434–441. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026